Stay informed of Noble in the news as we advance our mission to create advanced drug delivery system trainers for the world’s leading pharmaceutical companies, which, in the end, benefit millions of patients worldwide.
Nasal drug repurposing has seen a real resurgence recently, driven by several factors. From an economic perspective, partners benefit from reduced development costs, intellectual property (IP) creation, increased market share and extended lifecycle. The [...]
FOR IMMEDIATE RELEASE CONTACT: Carolyn Reis, APR, at Carolyn@ReisCorporatePR.com or (407) 590-0251 ORLANDO, Fla. (February 10, 2020) — Noble International, an industry leader in developing training devices and onboarding solutions for patients who self-administer [...]
Diagnoses of chronic illnesses such as rheumatoid arthritis (RA), Crohn’s disease and osteoporosis are expected to skyrocket in the coming decade, resulting in growing use of patient-centric drug delivery devices – including autoinjectors, prefilled [...]
Aptar Pharma, a leading drug delivery systems provider, announces its Platinum Sponsorship of this year’s Drug Delivery to the Lung (DDL) Conference 2019, which takes place from December 11-13 in Edinburgh, Scotland. DDL provides an [...]
Crystal Lake, Illinois, October 31, 2019 – AptarGroup, Inc. (NYSE: ATR), a global leader in consumer dispensing, active packaging and drug delivery solutions, announced today that, subsequent to the end of the quarter, it [...]